A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants

NCT01964872 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: JNJ-38877618: Part 1a
DRUG: JNJ-38877618: Part 1b
DRUG: JNJ-38877618: Part 1c (optional)
DRUG: JNJ-38877618: Part 2
DRUG: JNJ-38877618: Part 3
DRUG: JNJ-38877618: Part 4 (optional)
DRUG: Placebo: Parts 1a, 2, 3, and 4 (optional)

Sponsor

Janssen Cilag N.V./S.A.